Combination of anti-PD-1 and TLR agonist treatment promising in aggressive melanoma

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2018年 / 14卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：2333 / 2333
页数：1
相关论文
共 50 条
  • [1] Anti-PD-1 antibody treatment for melanoma
    Ribas, Antoni
    Kirkwood, John M.
    Flaherty, Keith T.
    LANCET ONCOLOGY, 2018, 19 (05): : E219 - E219
  • [2] Anti-PD-1 antibody treatment for melanoma Reply
    Beaver, Julia A.
    Keegan, Patricia
    Lemery, Steven
    Pazdur, Richard
    Theoret, Marc R.
    LANCET ONCOLOGY, 2018, 19 (05): : E220 - E220
  • [3] Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1
    Robert, Caroline
    Lebbe, Celeste
    Lesimple, Thierry
    Lundstrom, Eija
    Nicolas, Valerie
    Gavillet, Bruno
    Crompton, Philippa
    Baroudjian, Barouyr
    Routier, Emilie
    Lejeune, Ferdy J.
    CLINICAL CANCER RESEARCH, 2023, 29 (05) : 858 - 865
  • [4] Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
    Bhave, Prachi
    Ahmed, Tasnia
    Lo, Serigne N.
    Shoushtari, Alexander
    Zaremba, Anne
    Versluis, Judith M.
    Mangana, Joanna
    Weichenthal, Michael
    Si, Lu
    Lesimple, Thierry
    Robert, Caroline
    Trojanello, Claudia
    Wicky, Alexandre
    Heywood, Richard
    Tran, Lena
    Batty, Kathleen
    Dimitriou, Florentia
    Stansfeld, Anna
    Allayous, Clara
    Schwarze, Julia K.
    Mooradian, Meghan J.
    Klein, Oliver
    Mehmi, Inderjit
    Roberts-Thomson, Rachel
    Maurichi, Andrea
    Yeoh, Hui-Ling
    Khattak, Adnan
    Zimmer, Lisa
    Blank, Christian U.
    Ramelyte, Egle
    Kaehler, Katharina C.
    Roy, Severine
    Ascierto, Paolo A.
    Michielin, Olivier
    Lorigan, Paul C.
    Johnson, Douglas B.
    Plummer, Ruth
    Lebbe, Celeste
    Neyns, Bart
    Sullivan, Ryan
    Hamid, Omid
    Santinami, Mario
    McArthur, Grant A.
    Haydon, Andrew M.
    Long, Georgina, V
    Menzies, Alexander M.
    Carlino, Matteo S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (07)
  • [5] Anti-PD-1 Therapy in Melanoma
    Moreno, Blanca Hornet
    Parisi, Giulia
    Robert, Lidia
    Ribas, Anton
    SEMINARS IN ONCOLOGY, 2015, 42 (03) : 466 - 473
  • [6] Pembrolizumab joins the anti-PD-1 armamentarium in the treatment of melanoma
    Hersey, Peter
    Gowrishankar, Kavitha
    FUTURE ONCOLOGY, 2015, 11 (01) : 133 - 140
  • [7] Combination of Fruquintinib and Anti-PD-1 for the Treatment of Colorectal Cancer
    Wang, Yuanyuan
    Wei, Bin
    Gao, Jianhua
    Cai, Xiaomin
    Xu, Lingyan
    Zhong, Haiqing
    Wang, Binglin
    Sun, Yang
    Guo, Wenjie
    Xu, Qiang
    Gu, Yanhong
    JOURNAL OF IMMUNOLOGY, 2020, 205 (10): : 2905 - 2915
  • [8] Anti-PD-1 and Novel Combinations in the Treatment of Melanoma-An Update
    Gellrich, Frank Friedrich
    Schmitz, Marc
    Beissert, Stefan
    Meier, Friedegund
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [9] Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma
    Aya, Francisco
    Gaba, Lydia
    Victoria, Ivan
    Fernandez-Martinez, Aranzazu
    Tosca, Monica
    Prat, Aleix
    Arance, Ana
    FUTURE ONCOLOGY, 2016, 12 (23) : 2683 - 2688
  • [10] Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy
    Babacan, Nalan Akgul
    Eroglu, Zeynep
    CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
12345